List Title | APhA DrugInfoLine

Endocrinology

SORT BY: Most Recent Most Viewed

March 2, 2016

New guidance on management of diabetes in long-term care settings

READ

PREVIEW
The American Diabetes Association (ADA) has released new guidance on management of diabetes for residents in long-term care or skilled nursing facilities that focuses on simplified treatment...
March 2, 2016

Guidance on long-term use of osteoporosis drugs

READ

PREVIEW
Given the potential benefits and harms of long-term use of bisphosphonate therapy for the management of osteoporosis, the American Society for Bone and Mineral Research (ASBMR) released guidance...
December 2, 2015

Diabetes: New recommendations push for earlier screening

READ

PREVIEW
As part of a cardiovascular risk assessment, the U.S. Preventive Services Task Force (USPSTF) advises that adults 40 to 70 years of age who are overweight or obese and asymptomatic should be...
November 24, 2015

Vitamin D: No benefit in postmenopausal women

READ

PREVIEW
Use of high- or low-dose vitamin D supplementation in postmenopausal women with vitamin D deficiency resulted in no additional benefits compared with placebo in bone mineral density, muscle...
September 29, 2015

Obesity in children alters drug exposure, pharmacokinetics

READ

PREVIEW
A systematic review of 20 studies revealed clinically significant pharmacokinetic alterations in children compared with control participants who were not obese for more than one-half of the drugs...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.